000			01711 a2200469 4500
005			20250515112528.0
264		0	_c20080512
008			200805s 0 0 eng d
022			_a1525-4135
024	7		_a10.1097/QAI.0b013e31815b0d6f _2doi
040			_aNLM _beng _cNLM
100	1		_aTenore, Simone
245	0	0	_aSaquinavir plus lopinavir/ritonavir versus amprenavir plus lopinavir/ritonavir for treating highly resistant patients in Brazil. _h[electronic resource]
260			_bJournal of acquired immune deficiency syndromes (1999) _cApr 2008
300			_a526-8 p. _bdigital
500			_aPublication Type: Clinical Trial; Letter
650	0	4	_aAnti-HIV Agents _xtherapeutic use
650	0	4	_aAntiretroviral Therapy, Highly Active
650	0	4	_aBrazil
650	0	4	_aCD4 Lymphocyte Count
650	0	4	_aCarbamates _xtherapeutic use
650	0	4	_aDrug Resistance, Viral _xdrug effects
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aFurans
650	0	4	_aHIV Infections _xdrug therapy
650	0	4	_aHIV Protease Inhibitors _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aLopinavir
650	0	4	_aMale
650	0	4	_aPilot Projects
650	0	4	_aProspective Studies
650	0	4	_aPyrimidinones _xtherapeutic use
650	0	4	_aRitonavir _xtherapeutic use
650	0	4	_aSaquinavir _xtherapeutic use
650	0	4	_aSulfonamides _xtherapeutic use
650	0	4	_aTreatment Outcome
700	1		_aFerreira, Paolo A
700	1		_aDiaz, Ricardo Sobhie
773	0		_tJournal of acquired immune deficiency syndromes (1999) _gvol. 47 _gno. 4 _gp. 526-8
856	4	0	_uhttps://doi.org/10.1097/QAI.0b013e31815b0d6f _zAvailable from publisher's website
999			_c17834797 _d17834797